Dale Carnegie and Norman Vincent Peale notwithstanding, there are limits to the power of positive thinking when it comes to clinical trial recruitment. It’s a common problem in the industry […]
Risk-based monitoring (RBM) and risk-based quality management (RBQM) are “central to ensuring the safety of patients in clinical trials, and [are] expected to continue to grow in importance as [trials] […]
With its recently issued qualification opinion on the use of electronic source direct data capture (eSource DDC) in clinical trials, the European Medicines Agency (EMA) has, likely to the relief […]
“It’s time for perception to meet reality” regarding some common notions clinical trial stakeholders have about using health management apps during studies, according to Aaron Fleishman, director of market development […]
You may be well-dressed, surrounded by nice offices and utilizing the latest equipment, but you won’t be a truly effective clinical trial practitioner if you cannot show compassion and earn […]